Identification and validation of plasma-based protein biomarkers for cediranib and olaparib in GY005, phase III
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
NRG Oncology
Start Date
August 1, 2020
End Date
December 31, 2025
Administered By
Medicine, Medical Oncology
Awarded By
NRG Oncology
Start Date
August 1, 2020
End Date
December 31, 2025